← Back to Search

Herbal Supplement

Kava Dietary Supplement for Pharmacokinetics (KavaPK Trial)

Phase 2
Waitlist Available
Led By Carol Mathews, MD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline up to study completion date, an average of 1 year
Awards & highlights

KavaPK Trial Summary

This trialwill study if kava can help reduce anxiety in adults with GAD. Participants take 3 75mg capsules daily for one week in a double-blind, placebo-controlled trial.

KavaPK Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline up to study completion date, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline up to study completion date, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean PRKACA change to validate PRKACA change %

KavaPK Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Kava Pharmacokinetics GroupExperimental Treatment1 Intervention
75 mg kava dietary supplement capsules per day for one week.
Group II: PlaceboPlacebo Group1 Intervention
Three placebo capsule per day for one week
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Kava Dietary Supplement
2021
Completed Phase 2
~50

Find a Location

Who is running the clinical trial?

Thorne Research Inc.Industry Sponsor
10 Previous Clinical Trials
641 Total Patients Enrolled
1 Trials studying Pharmacokinetics
10 Patients Enrolled for Pharmacokinetics
University of FloridaLead Sponsor
1,339 Previous Clinical Trials
717,316 Total Patients Enrolled
2 Trials studying Pharmacokinetics
22 Patients Enrolled for Pharmacokinetics
Thorne HealthTech, IncIndustry Sponsor
10 Previous Clinical Trials
641 Total Patients Enrolled
1 Trials studying Pharmacokinetics
10 Patients Enrolled for Pharmacokinetics

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Florida
How old are they?
18 - 65
What site did they apply to?
UF CTSI Clinical Research Center
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Biomarker Changes and Anxiolytic Effects-Phase 2
2021. "Biomarker Changes and Anxiolytic Effects-Phase 2". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04565145.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top